Observational studyThe journal of prevention of Alzheimer's disease2025
Motor abilities and cognitive performance in Latinos with autosomal dominant Alzheimer's disease.
Observational study in The journal of prevention of Alzheimer's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Qifuyin improves physiological frailty by regulating the intestinal flora in 3xTg-AD mice.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundDeclining motor abilities might be a noninvasive biomarker for Alzheimer's disease (AD). Studying motor ability and AD progression in younger Latinos with autosomal dominant Alzheimer's disease (ADAD) can provide insights into the interplay between motor ability and cognition in individuals with minimal confounding from age-normative changes and comorbid medical conditions.
objectivesThis study aimed to (1) examine motor abilities as a function of years to dementia diagnosis and (2) examine associations between motor ability and cognitive performance.
designThis was a cross-sectional observational study.
settingThe study took place at the University of Southern California.
participants39 predominately Latino individuals (mean age 38.6 ± 10 years old) known to carry (carriers; n=25) or be at 50% risk for inheriting ADAD but not carrying the mutation (noncarriers; n=14). MEASUREMENTS: Individuals completed the motor and cognitive batteries from the National Institute of Health Toolbox (NIHTB) and the Cognitive Abilities Screening Instrument (CASI). All models included effects for age, education, primary language, and sex.
resultsCompared to noncarriers, ADAD mutation carriers had significantly weaker grip strength at 12 years, worse manual dexterity at 10 years, and slower gait speed seven years before the expected age of dementia diagnosis. Worse motor ability was associated with a more severe cognitive disease stage and worse CASI performance, adjusting for demographic and clinical variables.
conclusionsThe findings support the utility of motor performance, precisely grip strength, manual dexterity, and gait speed as potential biomarkers of preclinical AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.